semaglutide for food noise Users Report Major Reduction in “Food Noise” and Better Mental Well-Being: Findings from the INFORM Survey (EASD 2025) Ozempic users spark uptick in

doi:10.1007/s10753-022-01724-y 84

Broader Legal and Safety Landscape The GLP-1 litigation is one of the largest pharmaceutical MDLs in recent memory rivaling classic cases in scope and complexity, with thousands of plaintiffs and multiple defendants including major drug companies

While everyones timeline is unique, many patients experience weight loss within their first month of semaglutide treatment and observe significant results in 4 to 6 months

Originally developed for the treatment of type 2 diabetes mellitus, these agentsincluding semaglutide and tirzepatidehave demonstrated substantial efficacy in promoting weight loss and are increasingly reshaping therapeutic strategies for obesity, cardiovascular and kidney disease, and potentially substance use disorders.[1,2] Historically, paradigm-shifting therapeutics have periodically redefined clinical practice